Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A ophthalmic gel in moderate-to-severe aqueous-deficient dry eye
CTR20180115Phase 2Completed
- Sponsor
- Zhaoke Pharmaceutical (Hefei) Co., Ltd.
- Start
- May 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in dry eye syndrome (DED), sponsored by Zhaoke Pharmaceutical (Hefei) Co., Ltd.. Started May 2018; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20180115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180115.